Master of Science in Nursing (MSN) Student Scholarship

Date Written

Fall 2014

Document Type


Course Number

NURS 5330

Course Name

Advanced Pathophysiology

Professor’s Name

John D. Chovan, James R. Cacchillo


Pancreatic Adenocarcinoma, Patient Outcomes

Subject Categories

Medical Pathology | Neoplasms | Nursing


Intraductal papillary mucinous neoplasms (IPMN) are uncommon tumors arising from the main pancreatic duct, branching pancreatic ducts, or both. The “overall incidence of invasive carcinoma associated with resected IPMN has been reported to be 20-40%” (Mohri et al., 2011). Due to their malignant potential, these lesions, along with mucinous cystic neoplasms (MCN), are considered more worrisome, and often require surgical resection (Gallucci, Langellotto, De Ritis, & Uomo, 2012). Even after removal of a primary lesion, patients remain under surveillance to monitor for recurrence, the rate of which is approximately 6 % (Gallucci et al., 2012), and patients with main duct IPMN are at a higher risk for developing pancreatic , gastric and colon adenocarcinoma over their lifetimes (Sheth, Howell & Kent, 2014). While both main duct and side branch lesions are considered pre-malignant, management of IPMN has not been well-established (Mohri et al., 2011) and ranges from watchful waiting to surgical resection, depending upon the suspicion of malignancy, the operation required and the relative risk to the patient. A lower threshold for surgical resection is present for main duct IPMNs, as they have a higher risk of associated malignancy (Sahora & Castillo, 2014). The incidence of pancreatic adenocarcinoma arising from IPMN has been well documented (Mohri et al., 2011). This poster discusses one such case. The patient’s IPMN was initially discovered incidentally, during evaluation of an unrelated medical diagnosis. As practitioners, it is important to be able to recognize IPMN as pre-malignant lesions and to act quickly to identify patients requiring further work-up. Since the prognosis of pancreatic adenocarcinoma is dismal, the early identification and treatment of IPMN, or pre-malignant lesions is imperative to improve outcomes (Mohri et al., 2011).



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.